Applied UV to Host First Quarter 2022 Conference Call on May 24, 2022

Applied UV to Host First Quarter 2022 Conference Call on May 24, 2022
CANNANNEW REPORT

MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (“UVC”) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call and live webcast on Tuesday, May 24, 2022 at 9:00 am ET to review its financial results. First quarter 2022 financial results will be released after market close on Monday, May 23rd and will be available through the Investor Relations section of the company’s website at https://irdirect.net/AUVI. Conference Call/Webcast Information Applied UV’s management team will host an investor conference call and live webcast on May 24, 2022, at 9:00 am ET. Investors can access the live webcast via a link on Applied UV’s web site at https://www.webcaster4.com/Webcast/Page/2626/45615. For those planning to participate on the call, please dial +1-877-545-0320 (for domestic calls), or +1-973-528-0002 (for international calls), passcode 867374. A replay of the conference call will be available online on the Applied UV web site, and a dial-in replay will be available for one week following the call at +1-877-481-4010 (for domestic calls) or +1-919-882-2331 (for international calls), replay passcode 45615. About Applied UV Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries – SteriLumen, Inc. (“SteriLumen”) and Munn Works, LLC (“Munn Works”). SteriLumen’s connected platform for Data Driven Disinfection™ applies the power of ultraviolet light (UVC) to destroy pathogens safely, thoroughly, and automatically, addressing the challenge of healthcare-acquired infections (“HAIs”). Targeted for use in facilities that have high customer turnover such as hospitals, hotels, commercial facilities, and other public spaces, the Company’s Lumicide™ platform…

Excerpt only …
READ MORE BELOW
Source : Applied UV to Host First Quarter 2022 Conference Call on May 24, 2022

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.